explore -WSS

explore

author：focus 2025-09-28 02:28:56 - browse：338

Adam Feuerstein, upper left, moderated a panel with, clockwise, David Chang of Allogene Therapeutics, Rachel Haurwitz of Caribou Biosciences, and Lynelle Hoch of Bristol Myers Squibb. STAT

If you ask biopharma leaders what’s ahead for CAR-T cancer therapy, they say the future is bright. And that future will also look markedly different than it does today, three of them said at the STAT 2023 Future Summit on Wednesday.

Now in its second decade, the cell therapy — which attacks cancer by extracting white blood cells from a patient, genetically modifying them, and then re-infusing them to fight the cancer — has made remarkable strides. Biotech reporter Adam Feuerstein reminded panelists that Emily Whitehead, the first pediatric patient to receive the therapy at age 10, has just started college.

But for all its success in changing the lives of up to 7,000 patients to the point one can use the word “cure,” the field has been hampered by wait lists at manufacturers making these patient-specific, autologous therapies and a shortage of medical centers to administer them. Patients bear a burden, too: Training their B cells to attack their tumors requires an onerous depletion process before their cells can be taken out of their bodies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： Global cancer cases to surge 77% by 2050, WHO report says

WSS

Top private equity targets in 2023: cardiology, clinical trials, lasers

What’s missing from the debate over nursing home staff minimums

Surgery pushed Ben Carson to fame

Wellcome Trust names Røttingen as its new CEO

Life sciences deals on track to hit lowest point since 2017

340B reform proposal comes out of Senate working group

hotspot

explore

Wikipedia

Heart attack and stroke risk calculators need revising

Updated Covid vaccine has 54% effectiveness, new study suggests

Dobbs anniversary: the lost opportunity of abortion as health care

How doctors and nurses shape Google's AI

DIEP, the 'gold standard' of breast reconstruction, is under threat

Gritstone Bio's cancer vaccine test, and more on Novartis' deal

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Nick Jonas talks about managing diabetes along with his career

Hollywood unions extend contract negotiations for actors

Devoted Health’s losses in Medicare Advantage persist

explore

Eight reasons why you should get an updated Covid vaccine

European regulators recommend Amylyx's ALS drug be rejected

Bernie Sanders bashes nonprofit hospitals over their tax breaks

Female surgeons have lower rates of long

European regulators consider appeal over Amylyx ALS drug

Surgery pushed Ben Carson to fame

leisure time

entertainment

leisure time

focus